Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulators In Japan Cut Away At New Drug Review Time

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan is posting an overall improvement in shortening the average time it takes regulators to review new drugs, according to a government evaluation committee that rated the operational performance of the Pharmaceuticals and Medical Devices Agency

You may also be interested in...



Japanese Health Ministry To Ask Drug Makers To Submit Applications For 100-plus Pharmaceutical Products; Vows Quick Review Process

TOKYO - In an unusual move aimed at solving part of Japan's drug lag problem, the Ministry of Health, Labor and Welfare is set to ask pharmaceutical makers to submit applications to market a total of 109 drugs that have already been approved in other countries, an MHLW official said May 10

Japanese Health Ministry To Ask Drug Makers To Submit Applications For 100-plus Pharmaceutical Products; Vows Quick Review Process

TOKYO - In an unusual move aimed at solving part of Japan's drug lag problem, the Ministry of Health, Labor and Welfare is set to ask pharmaceutical makers to submit applications to market a total of 109 drugs that have already been approved in other countries, an MHLW official said May 10

Tokyo Aims To Speed Up Drug Approvals, Catch Up With U.S., Says Japanese Health Ministry Official

TOKYO - Japan is in the process of aligning itself with global pharmaceutical standards, according to Shuichi Kishida, councilor for pharmaceutical safety at the Ministry of Health, Labor and Welfare

UsernamePublicRestriction

Register

OM011995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel